Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR) Meeting Abstract
| Authors: | Feldman, D. R.; Stadler, W. M.; Appleman, L. J.; Quinn, D. I.; Costello, B. A.; Schwartz, G. K.; Reuter, V. E.; Woo, K.; Patil, S.; Fusco, A.; Smith, S. C.; Carlson, J.; Bosl, G. J.; Motzer, R. J. |
| Abstract Title: | Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR) |
| Meeting Title: | 2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2014 Jan 30-Feb 1 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-02-01 |
| Language: | English |
| ACCESSION: | WOS:000335318100365 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.4_suppl.364 |
| Notes: | Meeting Abstract: 364 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos |
